Your Mission is Our Mission
At ProPharma, we help pharmaceutical, biotechnology, and medical device companies bring life-changing therapies to market. From early development through clinical, regulatory approval, and commercialization, we provide expert guidance to navigate complex challenges and accelerate success.
Our mission is simple - improving patient health and safety by delivering the highest quality regulatory, compliance, clinical research, pharmacovigilance, and medical information services throughout the entire product lifecycle.
"We work in close partnership with our clients, often as an extension of their teams, to improve the health and safety of patients. Our ability to be nimble, coupled with a passion for excellence ensures our services exceed clients’ expectations."
Dawn Sherman
Board Chair & Chief Executive Officer
"We work in close partnership with our clients, often as an extension of their teams, to improve the health and safety of patients. Our ability to be nimble, coupled with a passion for excellence ensures our services exceed clients’ expectations."
Dawn Sherman
Board Chair & Chief Executive Officer
Dawn Sherman
Chief Executive Officer
Brian Tuttle
Chief Financial Officer
Jason DeGoes
President
Laura Hopper
President, Pharmacovigilance
.png?width=580&height=580&name=Rajul%20Jain%20(1).png)
Rajul Jain
President, Medical Information
Jim Kolbet
President, Quality and Compliance
Matthew Weinberg
President, Regulatory Sciences
Kevin Wysocki
President, Clinical Research Solutions
Rachel Bias
Chief Human Resources Officier
Kristin Ortlieb
Vice President, Quality & Training
Zosya Popik
Chief Marketing Officer
Andrew Shaw
General Counsel
Sara Sorrentino
Chief Business Development Officer
Kirk Wroblewski
Chief Information Officer
Our Path to Excellence
ProPharma’s growth over the past two decades reflects our mission. We continue to expand our global impact - helping our clients bring safe, effective therapies to patients who need them.
2001
2007
2011
2014
2015
2017
2018
2019
2021
2022
2023
Founded
ProPharma Group
Established as a leading provider of validation and other related life science consulting services in the pharmaceutical, biotechnology, and medical device industries.
Merged
Computer Compliance
Joined forces with Computer Compliance to deliver an enhanced experience in validation of automated systems, computers, and IT services.
Acquired
Advanced Response Management (ARM)
Expanded our suite of services to include medical information with the acquisition of Advanced Response Management (ARM), based in the United States.
Acquired
Professional Information Ltd
Further expanded our medical information capabilities with the acquisition of Professional Information Ltd (PI) operating in the United Kingdom and Australia.
Acquired
PROSAR
Acquired the leading provider of pharmacovigilance services, PROSAR, based in the United States, to complement our suite of MI services.
Acquired
Drug Safety Solutions
Further expanded our pharmacovigilance services with the acquisition of Drug Safety Solutions, a clinical safety company, based in the United States.
Expanded
Global Support
Expanded global support with new contact center in Tokyo, Japan.
Acquired
SOLUTIONS in Health
Acquired SOLUTIONS in Health, a Canada-based provider of medical information services.
Acquired
European-Based Xendo Life Sciences
Expanded our global reach and service offerings for compliance consulting, regulatory sciences, and pharmacovigilance with the acquisition of European-Based Xendo, which included Sofus Regulatory Affairs.
Acquired
The Weinberg Group and Southwood Research
Expanded our support for clients throughout all phases of the product lifecycle with the acquisitions of The Weinberg Group, a leading provider of regulatory sciences services based in the United States and Southwood Research, a pre-approval regulatory science services provider based in the United Kingdom.
Expanded
Global ProPharma Brand
United Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health under the global ProPharma brand.
Acquired
Pharmica Consulting
Acquired Pharmica Consulting, a life science consulting company that provides Project Management (PM) consulting solutions and proprietary operations software to pharmaceutical and biotech companies for the execution of clinical trials.
Acquired
iSafety Systems
Acquired iSafety Systems, a leading pharmacovigilance provider headquartered in India’s leading biotech hub, Hyderabad.
Merger
The Planet Group
ProPharma and The Planet Group, a leading provider of specialized consulting services and outsourced human capital solutions to the Life Sciences, Energy/Engineering, and Technology sectors, announced an agreement to merge the two companies.
Acquired
Diamond Pharma Services
Acquired Diamond Pharma Services, a leading regulatory sciences, pharmacovigilance, and compliance and quality consultancy headquartered in the United Kingdom, with offices in Europe.
Acquired
M Squared Associates (M2)
M Squared Associates (M2), an industry leading clinical, regulatory, and quality consulting firm serving the medical device and diagnostic industry.
Acquired
OneSource Regulatory (OSR) and OneSource Regulatory Technology (OSR-T)
OSR is an industry leading source for regulatory, medical, marketing operations, and compliance consulting services, including promotional and labeling review, and technology solutions.
Acquired
Kateric
Since 2004, Kateric has established a reputation as a strategic partner throughout the life sciences industry providing worldwide access to regulatory documentation services and capabilities over a range of product lifecycle needs
Acquired
Digital Lab Consulting
Since 2018, Digital Lab Consulting (DLC) has been a strategic partner, providing deep industry and digital transformation expertise to enable organizations to transform their business through better use of data and technology. DLC’s expertise covers a wide range of skill sets and capabilities across the pharma value chain.
Acquired
Clinres Farmacija
Clinres Farmacija is a leading Contract Research Organization based in Croatia. This move reinforces ProPharma's commitment to expanding its presence in Central and Eastern Europe, providing comprehensive clinical services.
2001
Founded
ProPharma Group
Established as a leading provider of validation and other related life science consulting services in the pharmaceutical, biotechnology, and medical device industries.
2007
Merged
Computer Compliance
Joined forces with Computer Compliance to deliver an enhanced experience in validation of automated systems, computers, and IT services.
2011
Acquired
Advanced Response Management (ARM)
Expanded our suite of services to include medical information with the acquisition of Advanced Response Management (ARM), based in the United States.
2014
Acquired
Professional Information Ltd
Further expanded our medical information capabilities with the acquisition of Professional Information Ltd (PI) operating in the United Kingdom and Australia.
2015
Acquired
PROSAR
Acquired the leading provider of pharmacovigilance services, PROSAR, based in the United States, to complement our suite of MI services.
2017
Acquired
Drug Safety Solutions
Further expanded our pharmacovigilance services with the acquisition of Drug Safety Solutions, a clinical safety company, based in the United States.
Expanded
Global Support
Expanded global support with new contact center in Tokyo, Japan.
2018
Acquired
SOLUTIONS in Health
Acquired SOLUTIONS in Health, a Canada-based provider of medical information services.
Acquired
European-Based Xendo Life Sciences
Expanded our global reach and service offerings for compliance consulting, regulatory sciences, and pharmacovigilance with the acquisition of European-Based Xendo, which included Sofus Regulatory Affairs.
2019
Acquired
The Weinberg Group and Southwood Research
Expanded our support for clients throughout all phases of the product lifecycle with the acquisitions of The Weinberg Group, a leading provider of regulatory sciences services based in the United States and Southwood Research, a pre-approval regulatory science services provider based in the United Kingdom.
Expanded
Global ProPharma Brand
United Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health under the global ProPharma brand.
2021
Acquired
Pharmica Consulting
Acquired Pharmica Consulting, a life science consulting company that provides Project Management (PM) consulting solutions and proprietary operations software to pharmaceutical and biotech companies for the execution of clinical trials.
Acquired
iSafety Systems
Acquired iSafety Systems, a leading pharmacovigilance provider headquartered in India’s leading biotech hub, Hyderabad.
Merger
The Planet Group
ProPharma and The Planet Group, a leading provider of specialized consulting services and outsourced human capital solutions to the Life Sciences, Energy/Engineering, and Technology sectors, announced an agreement to merge the two companies.
Acquired
Diamond Pharma Services
Acquired Diamond Pharma Services, a leading regulatory sciences, pharmacovigilance, and compliance and quality consultancy headquartered in the United Kingdom, with offices in Europe.
2022
Acquired
M Squared Associates (M2)
M Squared Associates (M2), an industry leading clinical, regulatory, and quality consulting firm serving the medical device and diagnostic industry.
Acquired
OneSource Regulatory (OSR) and OneSource Regulatory Technology (OSR-T)
OSR is an industry leading source for regulatory, medical, marketing operations, and compliance consulting services, including promotional and labeling review, and technology solutions.
Acquired
Kateric
Since 2004, Kateric has established a reputation as a strategic partner throughout the life sciences industry providing worldwide access to regulatory documentation services and capabilities over a range of product lifecycle needs
2023
Acquired
Digital Lab Consulting
Since 2018, Digital Lab Consulting (DLC) has been a strategic partner, providing deep industry and digital transformation expertise to enable organizations to transform their business through better use of data and technology. DLC’s expertise covers a wide range of skill sets and capabilities across the pharma value chain.
Acquired
Clinres Farmacija
Clinres Farmacija is a leading Contract Research Organization based in Croatia. This move reinforces ProPharma's commitment to expanding its presence in Central and Eastern Europe, providing comprehensive clinical services.
North America
United Kingdom
Europe
Asia Pacific
Washington, DC
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
US
Raleigh (HQ)
107 West Hargett St.
Raleigh, NC 27601
Bozeman
274 Discovery Dr, Suite 100 Bozeman, MT 59718
Chicago (Deerfield)
10 Parkway North, Suite 310
Deerfield, IL 60015
Chicago (Loop)
200 N. Lasalle Street, Suite 2450
Chicago, IL 60601
Washington, DC
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
UK
London
John Stow House 18
Bevis Mark
London EC3A 7JB
North Yorkshire
Olliver, Aske, Richmond
North Yorkshire, DL10 5HX
Europe
Berlin
Siemensdamm 62
13627 Berlin
Leiden
Schipholweg 59
2316 ZL Leiden
Lund
Medicon Village
223 81 LUND
Stockholm
Fleminggatan 18
SE -112 26 Stockholm
Zagreb
Ulica grada Vukovara 269a, 10000 Zagreb, Croatia
Sarajevo
Alipašina 29, 71000 Sarajevo, Bosnia and Herzegovina
Belgrade (Main)
Beogradskog Bataljona 4, 11000 Belgrade, Serbia
Belgrade
Nedeljka Čabrinovića 65, 11000 Belgrade, Serbia
Podgorica
Bul. Svetoga Petra Cetinjskog 114/I, 81000 Podgorica, Crna Gora
Skopje
Ul. Arso Mickov 29, 1060 Skopje, Macedonia
Skopje (Office)
st. Fjodor Dostoevski no. 72 (Industrila zone Karpos area Vlae), Skopje
Brasov
Saturn Boulevard no. 42/A 3rd floor, Ap. 13, 500164 Brasov, Romania
Tbilisi
Shartava Street, # 40, Tbilisi, Georgia
Tirana
Rruga Xhanfize Keko Nr. 56, Njesia Administrative 12, H 2, Z. 505, Tirana, Albania.
Asia Pacific
Melbourne
Suite 6, Ground Level
452 Johnston Street
Abbotsford, VIC 3067
Hyderabad
3rd Block, 7th Floor,
My Home Hub, Madhapur, Patrika Nagar, HITEC City,
Hyderabad, Telangana 500081
Tokyo
16F Link Square Shinjuku
5-27-5 Sendagaya, Shibuya-ku, Tokyo, 151-0051
Japan
Makati City
7th Floor Office F
Armstrong Corporate Center
HV Dela Costa Ave.
Salcedo Village
Makati City
Shanghai
138 HuaiHai Zhong Lu
3F
Huangpu District
Shanghai
ProPharma News
Explore ProPharma's latest news and accolades
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for...
ProPharma Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: ProPharma, a leading global provider of regulatory, clinical, and...
ProPharma Names Dawn Sherman Chief Executive Officer
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Honored in the 2024 Clinical Trials Excellence Awards
ProPharma has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...
ProPharma News
Explore ProPharma's latest news and accolades
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – ProPharma, the leading global provider of regulatory, clinical, and compliance services for...
ProPharma Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
Regulatory and Compliance excellence recognized for innovation across the product development lifecycle RALEIGH, NC, October 9, 2024: ProPharma, a leading global provider of regulatory, clinical, and...
ProPharma Names Dawn Sherman Chief Executive Officer
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
ProPharma Honored in the 2024 Clinical Trials Excellence Awards
ProPharma has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...
Diversity, Equity & Inclusion
ProPharma celebrates our differences and strives to create a workplace where each person can be their authentic self. We are committed to diversity, equity, and inclusion. Employees are encouraged to unleash their innovative, collaborative, and entrepreneurial spirits. With a holistic approach as an Equal Opportunity Employer, we provide a safe space where all employees feel empowered to succeed.
Sustainability Framework
ProPharma recognizes the critical importance of sustainability both in shaping a better future for our world and as an investment in the health of our business. As an essential component of modern corporate strategy, we developed a comprehensive sustainability policy centered around the key themes of People-Centric Culture, Ethical Leadership, and Climate Stewardship.